General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Streptococcus peroris is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, coccus bacterium. It has been detected in at least 6 gut microbiome compilation studies or metastudies. The DNA G+C content is 39.8-40.5%. Streptococcus peroris is probably a rare gut coloniser. (Kawamura1998; Whiley2011Bergey)



  • This organism has been recovered from dental, clinical sources (pharynx) and human faeces. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Can cause opportunistic infections, particularly in immunocompromised people. Likely to be transient and not a long-term gut commensal. Robust growth can have unknown consequences for gut health.

  • GENERAL CHARACTERISTICS (Kawamura1998); (Whiley2011Bergey);
    Character Response
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; lactose; maltose; sucrose;
  • Active enzymes:
  • Ala-Phe-Pro arylamidase; alkaline phosphatase;

  • SPECIAL FEATURES (Whiley2011Bergey);
    Character Response
  • Metabolites produced:
  • lactate;
  • Metabolites not produced:
  • indole;
  • VP test:
  • not active
  • Haemolysis:
  • alpha
  • Nitrate:
  • not reduced

  • Streptococci are members of the normal flora. Virulence factors of group A streptococci include (1) M protein and lipoteichoic acid for attachment; (2) a hyaluronic acid capsule that inhibits phagocytosis; (3) other extracellular products, such as pyrogenic (erythrogenic) toxin, which causes the rash of scarlet fever; and (4) streptokinase, streptodornase (DNase B), and streptolysins. Some strains are nephritogenic. Immune-mediated sequelae do not reflect dissemination of bacteria. Nongroup A strains have no defined virulence factors. In humans, diseases associated with the streptococci occur chiefly in the respiratory tract, bloodstream, or as skin infections. [https://www.ncbi.nlm.nih.gov/books/NBK7611/]

  • GutFeeling KnowledgeBase COMMENTS [Website]

    The genus Streptococcus , a heterogeneous group of Gram-positive bacteria, has broad significance in medicine and industry. Various streptococci are important ecologically as part of the normal microbial flora of animals and humans; some can also cause diseases that range from subacute to acute or even chronic. Among the significant human diseases attributable to streptococci are scarlet fever, rheumatic heart disease, glomerulonephritis, and pneumococcal pneumonia. Streptococci are essential in industrial and dairy processes and as indicators of pollution. [https://www.ncbi.nlm.nih.gov/books/NBK7611/]

  • Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.


  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Lactobacillales Family:  Streptococcaceae Genus:  Streptococcus Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccus
    Health:  Unknown
    Source:  dental, clinical sources (pharynx) and human faeces
    DNA G+C(%):  39.8-40.5
    Aesculin:  neg Urea:  neg Arginine:  neg Hippurate:  vr

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg D-Arabinose:  neg L-Arabinose:  neg Glucose:  + Ribose:  neg D-Tagatose:  neg Lactose:  + Maltose:  + Melezitose:  neg Melibiose:  neg Sucrose:  + Trehalose:  neg Amygdalin:  neg Dextrin:  neg Glycogen:  neg Inulin:  neg D-Arabitol:  neg Mannitol:  neg Sorbitol:  neg Arbutin:  neg Me-α-D-Glc:  neg

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Melibiose:  neg Hippurate:  neg

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  neg Ac-β-glcamnd:  neg α-Galactosidase:  neg β-Galactosidase:  vr β-Glucosidase:  neg β-Glucuronidase:  neg β-Mannosidase:  neg ArgDH:  neg AlaPheProAA:  + GlyTrpAA:  neg PyrrolidAA:  neg AlkalineP:  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Lactate:  + Indole:  neg

    References


    SPECIFIC REFERENCES FOR STREPTOCOCCUS PERORIS
  • Kawamura1998 - Streptococcus peroris sp. nov. and Streptococcus infantis sp. nov., new members of the Streptococcus mitis group, isolated from human clinical specimens.
  • Whiley2011Bergey - Bergey's manual of systematic bacteriology. Vol. 3, The Firmicutes. Family Streptococcaceae, Genus I. Streptococcus
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR STREPTOCOCCUS PERORIS
  • Dubinkina2017 - Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................
  • GENERAL REFERENCES FOR STREPTOCOCCUS PERORIS
  • Ludwig2009 - Revised road map to the phylum Firmicutes.